Literature DB >> 28493543

Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.

Melissa R Partin1,2, Amy A Gravely1, James F Burgess3,4, David A Haggstrom5,6, Sarah E Lillie1,2, David B Nelson1,2, Sean M Nugent1, Aasma Shaukat1,2, Shahnaz Sultan1,2, Louise C Walter7, Diana J Burgess1,2.   

Abstract

BACKGROUND: Patient, physician, and environmental factors were identified, and the authors examined the contribution of these factors to demographic and health variation in colonoscopy follow-up after a positive fecal occult blood test/fecal immunochemical test (FOBT/FIT) screening.
METHODS: In total, 76,243 FOBT/FIT-positive patients were identified from 120 Veterans Health Administration (VHA) facilities between August 16, 2009 and March 20, 2011 and were followed for 6 months. Patient demographic (race/ethnicity, sex, age, marital status) and health characteristics (comorbidities), physician characteristics (training level, whether primary care provider) and behaviors (inappropriate FOBT/FIT screening), and environmental factors (geographic access, facility type) were identified from VHA administrative records. Patient behaviors (refusal, private sector colonoscopy use) were estimated with statistical text mining conducted on clinic notes, and follow-up predictors and adjusted rates were estimated using hierarchical logistic regression.
RESULTS: Roughly 50% of individuals completed a colonoscopy at a VHA facility within 6 months. Age and comorbidity score were negatively associated with follow-up. Blacks were more likely to receive follow-up than whites. Environmental factors attenuated but did not fully account for these differences. Patient behaviors (refusal, private sector colonoscopy use) and physician behaviors (inappropriate screening) fully accounted for the small reverse race disparity and attenuated variation by age and comorbidity score. Patient behaviors (refusal and private sector colonoscopy use) contributed more to variation in follow-up rates than physician behaviors (inappropriate screening).
CONCLUSIONS: In the VHA, blacks are more likely to receive colonoscopy follow-up for positive FOBT/FIT results than whites, and follow-up rates markedly decline with advancing age and comorbidity burden. Patient and physician behaviors explain race variation in follow-up rates and contribute to variation by age and comorbidity burden. Cancer 2017;123:3502-12. Published 2017. This article is a US Government work and is in the public domain in the USA.
© 2017 American Cancer Society.

Entities:  

Keywords:  colonoscopy; colorectal neoplasms; diagnostic services; early detection of cancer; health services accessibility; mass screening; veterans health

Mesh:

Year:  2017        PMID: 28493543      PMCID: PMC5589505          DOI: 10.1002/cncr.30765

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  43 in total

1.  Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration.

Authors:  Mary Beth Landrum; Nancy L Keating; Elizabeth B Lamont; Samuel R Bozeman; Barbara J McNeil
Journal:  Cancer       Date:  2011-11-09       Impact factor: 6.860

2.  The impact of a quality assessment program on the practice behavior of general practitioners: a follow-up study.

Authors:  A L Morris; A A Vito; M R Bomba; J M Bentley
Journal:  J Am Dent Assoc       Date:  1989-12       Impact factor: 3.634

Review 3.  Health disparities in colorectal cancer among racial and ethnic minorities in the United States.

Authors:  Christian S Jackson; Matthew Oman; Aatish M Patel; Kenneth J Vega
Journal:  J Gastrointest Oncol       Date:  2016-04

4.  Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening.

Authors:  R E Myers; T Hyslop; M Gerrity; N Schlackman; N Hanchak; J Grana; B J Turner; D Weinberg; W W Hauck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-07       Impact factor: 4.254

5.  Veterans' access to and use of Medicare and Veterans Affairs health care.

Authors:  Denise M Hynes; Kristin Koelling; Kevin Stroupe; Noreen Arnold; Katherine Mallin; Min-Woong Sohn; Frances M Weaver; Larry Manheim; Linda Kok
Journal:  Med Care       Date:  2007-03       Impact factor: 2.983

6.  Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?

Authors:  Charlotte M Carlson; Katharine A Kirby; Michele A Casadei; Melissa R Partin; Christine E Kistler; Louise C Walter
Journal:  Arch Intern Med       Date:  2010-10-11

7.  Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test.

Authors:  Barbara Turner; Ronald E Myers; Terry Hyslop; Walter W Hauck; David Weinberg; Timothy Brigham; James Grana; Todd Rothermel; Neil Schlackman
Journal:  J Gen Intern Med       Date:  2003-05       Impact factor: 5.128

8.  Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation.

Authors:  Masahito Jimbo; Ronald E Myers; Birgit Meyer; Terry Hyslop; James Cocroft; Barbara J Turner; David S Weinberg
Journal:  Ann Fam Med       Date:  2009 Jan-Feb       Impact factor: 5.166

9.  Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries.

Authors:  Gregory S Cooper; Siran M Koroukian
Journal:  Cancer       Date:  2004-01-15       Impact factor: 6.860

10.  Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.

Authors:  Jessica Chubak; Michael P Garcia; Andrea N Burnett-Hartman; Yingye Zheng; Douglas A Corley; Ethan A Halm; Amit G Singal; Carrie N Klabunde; Chyke A Doubeni; Aruna Kamineni; Theodore R Levin; Joanne E Schottinger; Beverly B Green; Virginia P Quinn; Carolyn M Rutter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

View more
  18 in total

1.  Complicating "the good result": narratives of colorectal cancer screening when cancer is not found.

Authors:  Jean M Hunleth; Robert Gallo; Emily K Steinmetz; Aimee S James
Journal:  J Psychosoc Oncol       Date:  2019-02-04

2.  Making FIT Count: Maximizing Appropriate Use of the Fecal Immunochemical Test for Colorectal Cancer Screening Programs.

Authors:  Vivy T Cusumano; Folasade P May
Journal:  J Gen Intern Med       Date:  2020-03-03       Impact factor: 5.128

3.  Patient Navigation After Positive Fecal Immunochemical Test Results Increases Diagnostic Colonoscopy and Highlights Multilevel Barriers to Follow-Up.

Authors:  Vivy T Cusumano; Anthony Myint; Edgar Corona; Liu Yang; Jennifer Bocek; Antonio G Lopez; Marcela Zhou Huang; Naveen Raja; Anna Dermenchyan; Lily Roh; Maria Han; Daniel Croymans; Folasade P May
Journal:  Dig Dis Sci       Date:  2021-02-20       Impact factor: 3.199

4.  Extent of Follow-Up on Abnormal Cancer Screening in Multiple California Public Hospital Systems: A Retrospective Review.

Authors:  Elaine C Khoong; Natalie A Rivadeneira; Lucia Pacca; Dean Schillinger; David Lown; Palav Babaria; Neha Gupta; Rajiv Pramanik; Helen Tran; Tyler Whitezell; Ma Somsouk; Urmimala Sarkar
Journal:  J Gen Intern Med       Date:  2022-05-31       Impact factor: 6.473

5.  Barriers associated with inadequate follow-up of abnormal fecal immunochemical test results in a safety-net system: A mixed-methods analysis.

Authors:  Rachel B Issaka; Ari Bell-Brown; Jason Kao; Cyndy Snyder; Dana L Atkins; Lisa D Chew; Bryan J Weiner; Lisa Strate; John M Inadomi; Scott D Ramsey
Journal:  Prev Med Rep       Date:  2022-05-18

6.  Hepatitis C Virus Screening: Factors Associated With Test Completion in a Large Academic Health Care System.

Authors:  Monica L Kasting; Shannon M Christy; Richard R Reich; Julie A Rathwell; Richard G Roetzheim; Susan T Vadaparampil; Anna R Giuliano
Journal:  Public Health Rep       Date:  2021-10-25       Impact factor: 3.117

7.  Trends in Wait Time for Outpatient Colonoscopy in the Veterans Health Administration, 2008-2015.

Authors:  Megan A Adams; Joel H Rubenstein; Rachel Lipson; Robert G Holleman; Sameer D Saini
Journal:  J Gen Intern Med       Date:  2020-03-24       Impact factor: 5.128

8.  Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type.

Authors:  Nancy Breen; Celette Sugg Skinner; Yingye Zheng; Stephen Inrig; Douglas A Corley; Elisabeth F Beaber; Mike Garcia; Jessica Chubak; Chyke Doubeni; Virginia P Quinn; Jennifer S Haas; Christopher I Li; Karen J Wernli; Carrie N Klabunde
Journal:  Am J Prev Med       Date:  2019-05       Impact factor: 5.043

9.  Time to Colonoscopy After Abnormal Stool-Based Screening and Risk for Colorectal Cancer Incidence and Mortality.

Authors:  Yazmin San Miguel; Joshua Demb; Maria Elena Martinez; Samir Gupta; Folasade P May
Journal:  Gastroenterology       Date:  2021-02-02       Impact factor: 22.682

Review 10.  Black and White Differences in Colorectal Cancer Screening and Screening Outcomes: A Narrative Review.

Authors:  Carolyn M Rutter; Amy B Knudsen; Jennifer S Lin; Kathryn E Bouskill
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-11-03       Impact factor: 4.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.